Could GW Pharmaceuticals see the same success with Sativex that they now have with Epidiolex?
October 1, 2018
GW Pharmaceuticals has chosen the perfect moment to file its cannabis-derived therapy, Epidiolex, with U.S. regulators. The New England…
May 31, 2017
In June, the U.S. government lifted restrictions on scientific research into the medical and therapeutic benefits of marijuana,…
July 28, 2015